Neurosensory dysphagia in a COVID-19 patient

Alessia Zanon; Laura Cacciaguerra; Gabriele Martelli; Massimo Filippi

doi:10.1007/s00415-021-10541-6

Article2022

Use of Remdesivir in severe COVID-19 Pregnant Patient

Ajeet Kumar, Neeraj Kumar, Saravanan Palavesam, Chethan Vamshi

Article2022

Severe progression of autoimmune hepatitis in a young COVID-19 adult patient

Neeraj Kumar, Sushant Satyapriya, Shaik Mohammad Tahaseen, Kunal Singh, Amarjeet Kumar

Article2020

Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19

Michalis Liontos, Maria Kaparelou, Emmanouil Karofylakis, Dimitra Kavatha, Αndreas Mentis, Flora Zagouri, Evangelos Terpos, Meletios A Dimopoulos

Article2024

Physical activity during COVID-19 in people with systemic sclerosis: A Scleroderma Patient-centred Intervention Network COVID-19 Cohort longitudinal study

Amanda Wurz, Richard S. Henry, Linda Kwakkenbos, Marie‐Eve Carrier, Scott Burton Patten, Susan J. Bartlett, Luc Mouthon, John Varga, Andrea Benedetti, S. Nicole Culos‐Reed, Brett D. Thombs

Article2020

Factors associated with fears due to COVID-19: A Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 cohort study

Yin Wu, Linda Kwakkenbos, Richard S. Henry, Marie‐Eve Carrier, Maria Gagarine, Sami Harb, Angelica Bourgeault, Lydia Tao, Andrea Carboni-Jiménez, Zelalem Negeri, Scott Burton Patten, Susan J. Bartlett, Luc Mouthon, John Varga, Andrea Benedetti, Brett D. Thombs, Catherine Fortuné, Amy Gietzen, Geneviève Guillot, Nancy Lewis, Michelle Richard, Maureen Sauvé, Joep Welling,

Neurosensory dysphagia in a COVID-19 patient

Discussion(0)

Related publications

Use of Remdesivir in severe COVID-19 Pregnant Patient

Severe progression of autoimmune hepatitis in a young COVID-19 adult patient

Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19

Physical activity during COVID-19 in people with systemic sclerosis: A Scleroderma Patient-centred Intervention Network COVID-19 Cohort longitudinal study

Factors associated with fears due to COVID-19: A Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 cohort study